MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-02-0004439
Lucent Drugs Private Limited - chemicals in Sanathnagar, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹104.13 Cr
▲ 101% YoY
Net profit · FY 2025
₹6.72 Cr
Net margin 6.4%
EBITDA · FY 2025
₹14.08 Cr
EBITDA margin 13.5%
Authorised capital
₹9 Cr
Registered with MCA
Paid-up capital
₹6.28 Cr
Issued & subscribed
Open charges
₹19.54 Cr
Satisfied ₹16.1 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
63
Provident fund records
About Lucent Drugs Private Limited
Data last updated:
Lucent Drugs Private Limited is a private limited company based in Sanathnagar, Telangana, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 02 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2017PTC118662. Its GSTIN is 36AADCL3750A1ZY (Telangana).
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹6.28 Cr. It is led by directors Sreenivasulu Devarasetty and Mahaveer Chand Jain.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No.W – 109 Svss Nivas Oppo.Gokul Theatre Czech Colony Street No.1, Sanathnagar, Telangana, India – 500018.
As per the financials filed for FY 2025, the company reported a revenue of ₹104.13 Cr, a growth of 101% compared to the previous year. For the same year it recorded a net profit of ₹6.72 Cr (net margin 6.4%) and EBITDA of ₹14.08 Cr (EBITDA margin 13.5%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 30% over five years.
The company has about 63 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹19.54 Cr and satisfied charges of ₹16.1 Cr on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 4 cases are pending.
Lucent Drugs Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0004439). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lucentdrugs.com.
Company details
CIN U24100TG2017PTC118662
Registration Number 118662
Incorporation Date 02 August 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-02-0004439
Recognitions & Rankings of Lucent Drugs
Contact details
Lucent Drugs Private Limited's registered office is in Sanathnagar, Telangana. Its website is lucentdrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No.W – 109 Svss Nivas Oppo.Gokul Theatre Czech Colony Street No.1, Sanathnagar, Telangana, India – 500018
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Lucent Drugs Private Limited, buy the company report.
Comprehensive company report
Lucent Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Lucent Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lucent Drugs Private Limited, buy the company report.
Financials of Lucent Drugs Private Limited
FY 2024 filings availableLucent Drugs Private Limited reported revenue of ₹104.13 Cr (up 101% YoY) for FY 2025.
Revenue · FY 2025
₹104.13 Cr ▲ 101%
Net profit · FY 2025
₹6.72 Cr margin 6.4%
EBITDA · FY 2025
₹14.08 Cr margin 13.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 101%
3 years · compounded
▲ 23%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 134%
3 years · compounded
▲ 15%
5 years · compounded
▲ 44%
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 101% growth in the latest year. EBITDA rose 134% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.08 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.72 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.5% | ||||
| Net Profit Margin | 6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lucent Drugs Private Limited, buy the company report.
Board of directors of Lucent Drugs Private Limited
Lucent Drugs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreenivasulu Devarasetty | Director | 02 Aug 2017 | 9 Years 2 Months | Current |
| Mahaveer Chand Jain | Director | 14 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Lucent Drugs Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Almelo Private Limited | ₹108.05 Cr (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Virdev Intermediates Private Limited | ₹107.72 Cr (FY 2025) | -3.0% | Surat, Gujarat, India | |||
| Panchsheel Organics Limited | ₹107.68 Cr (FY 2024) | 3.0% | Indore, Madhya Pradesh, India | |||
| Patel Chem Specialities Limited | ₹105.55 Cr (FY 2025) | 28.0% | Ahmedabad, Gujarat, India | |||
| Lucent Drugs Private Limitedthis company | ₹104.13 Cr (FY 2025) | ₹6.72 Cr | 6.4% | 101.0% | 63 | Sanathnagar, Telangana, India |
| Novo Excipients Private Limited | ₹103.54 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Par Active Technologies Private Limited | ₹103.46 Cr (FY 2025) | 2.0% | Chennai, Tamil Nadu, India | |||
| Avik Pharmaceutical Limited | ₹103.38 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Sriven Pharmachem India Private Limited | ₹102.76 Cr (FY 2025) | 2.0% | Hyderabad, Telangana, India | |||
| Vineet Life Sciences Limited | ₹101.85 Cr (FY 2024) | 48.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Lucent Drugs Private Limited, buy the company report.
Auditor
Lucent Drugs Private Limited is audited by K A R A & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K A R A & Associates | FY 2023 | 013975S |
Shareholding
The shareholding of Lucent Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lucent Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹19.54 Cr
Satisfied charges
₹16.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2025 | 101071437 | Hdfc Bank Limited | ₹20.15 Lakh | Open | |
| 26 Aug 2024 | 100986511 | Standard Chartered Bank | ₹18.89 Cr | Open | |
| 02 Dec 2022 | 100660768 | Hdfc Bank Limited | ₹23.26 Lakh | Open | |
| 21 Oct 2022 | 100640164 | Hdfc Bank Limited | ₹22.08 Lakh | Open | |
| 28 Mar 2018 | 100173302 | State Bank of India | ₹16.1 Cr | Satisfied |
To see the full charge records of Lucent Drugs Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Lucent Drugs Private Limited has 7 court cases on record: 3 filed by Lucent Drugs, 4 filed against it. 4 cases are pending and 3 are disposed.
Total cases
7
Filed by the company
3
Filed against the company
4
Pending
4
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 2 | 3 |
| High courts | 3 | 2 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Court case (COS) | Filed by the company against an individual | Pending |
| District court, Hyderabad Central, Telangana | Criminal case | Filed against the company by an individual | Pending |
| District court, Hyderabad Central, Telangana | Civil suit | Filed by the company against individuals | Pending |
| High Court, TELANGANA | Writ petition | Filed against the company by an individual | Pending |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Lucent Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lucent Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lucent Drugs Private Limited has a workforce of 63 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
63
Active EPFO establishments
1
Employee growth
43.18%
GST
Lucent Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCL3750A1ZY | Telangana | Active | 12 Sep 2017 |
To see the full GST registrations and return filing status of Lucent Drugs Private Limited, buy the company report.
Recent activity
Lucent Drugs Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Mahaveer Chand Jain ceased to be Additional Director on 30 Sep 2022.
Charges
A charge with Standard Chartered Bank of Rs. 18.89 Cr registered on 26 Aug 2024 with Charge ID 100986511 was modified on 27 Jun 2025.
Charges
A charge registered on 28 Mar 2018 via Charge ID 100173302 with State Bank Of India was fully satisfied on 24 Mar 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 101071437 was registered on 21 Mar 2025.
AGM
Lucent Drugs Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Charges
A charge with Standard Chartered Bank amounted to Rs. 18.89 Cr with Charge ID 100986511 was registered on 26 Aug 2024.
Filing
Lucent Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 100660768 was registered on 02 Dec 2022.
Charges
A charge with State Bank Of India of Rs. 16.10 Cr registered on 28 Mar 2018 with Charge ID 100173302 was modified on 16 Nov 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 100640164 was registered on 21 Oct 2022.
Ceased
Mahaveer Chand Jain ceased to be Additional Director.
Ceased
Sai Vikas Devarasetty ceased to be Additional Director.
Appointed
Mahaveer Chand Jain was appointed as Director.
4 earlier events are in the company report.
Frequently asked questions
Lucent Drugs is an active private limited company based in Sanathnagar, Telangana, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 02 August 2017 (9+ years old) and is registered under CIN U24100TG2017PTC118662.
Lucent Drugs has 2 current directors:
- Sreenivasulu Devarasetty - Director
- Mahaveer Chand Jain - Director
The latest financial statements of Lucent Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Lucent Drugs is 36AADCL3750A1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Lucent Drugs is U24100TG2017PTC118662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lucent Drugs has 7 court cases on record: 3 filed by the company and 4 filed against it. 4 are pending. Most are in the district courts.
Lucent Drugs was incorporated on 02 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Lucent Drugs by revenue are Almelo Private Limited, Virdev Intermediates Private Limited, Panchsheel Organics Limited, Patel Chem Specialities Limited, Novo Excipients Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mahaveer Chand Jain ceased to be Additional Director on 30 Sep 2022. Sai Vikas Devarasetty ceased to be Additional Director on 30 Sep 2022. Mahaveer Chand Jain was appointed as Director on 14 Jun 2022. Lucent Drugs has 5 board changes on record in total.
Yes, Lucent Drugs is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0004439).
Lucent Drugs can be reached through the website lucentdrugs.com. Its registered office is in Sanathnagar, Telangana, India.